DE69739190D1 - Arzneimittel zur behandlung von oculären kreislauferkrankungen - Google Patents
Arzneimittel zur behandlung von oculären kreislauferkrankungenInfo
- Publication number
- DE69739190D1 DE69739190D1 DE69739190T DE69739190T DE69739190D1 DE 69739190 D1 DE69739190 D1 DE 69739190D1 DE 69739190 T DE69739190 T DE 69739190T DE 69739190 T DE69739190 T DE 69739190T DE 69739190 D1 DE69739190 D1 DE 69739190D1
- Authority
- DE
- Germany
- Prior art keywords
- ocular
- crush
- medicament
- diseases
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28568496 | 1996-10-28 | ||
| JP24555997 | 1997-09-10 | ||
| PCT/JP1997/003866 WO1998018471A1 (fr) | 1996-10-28 | 1997-10-23 | Medicaments pour le traitement des troubles circulatoires oculaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69739190D1 true DE69739190D1 (de) | 2009-02-12 |
Family
ID=26537282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69739190T Expired - Lifetime DE69739190D1 (de) | 1996-10-28 | 1997-10-23 | Arzneimittel zur behandlung von oculären kreislauferkrankungen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6451799B1 (de) |
| EP (1) | EP0968716B1 (de) |
| JP (1) | JP4828670B2 (de) |
| CA (1) | CA2270119A1 (de) |
| DE (1) | DE69739190D1 (de) |
| ES (1) | ES2317650T3 (de) |
| WO (1) | WO1998018471A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000044383A1 (fr) * | 1999-01-29 | 2000-08-03 | Senju Pharmaceutical Co., Ltd. | Agents anti-inflammatoires et inhibiteurs contenant des derives de 1,4-dihydropyridine reduisant l'augmentation de la tension oculaire provoquee par une irradiation par laser |
| CA2369299A1 (en) * | 1999-04-14 | 2000-10-19 | Senju Pharmaceutical Co., Ltd. | Inhibitor of visual function disturbance caused by optic nerve cell disorder due to factor other than ophthalmic circulatory disorder |
| US8088773B2 (en) * | 2005-05-12 | 2012-01-03 | The Texas A&M University System | Therapeutic compositions and methods |
| WO2012125872A2 (en) * | 2011-03-15 | 2012-09-20 | University Of Utah Research Foundation | Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof |
| CN104768533A (zh) | 2012-06-11 | 2015-07-08 | 马库克利尔公司 | 治疗性制剂和治疗方法 |
| ITUB20169937A1 (it) | 2016-01-12 | 2017-07-12 | Medical And Biotechnological Services In Sigla M B S Srl | Formulazioni farmaceutiche e loro uso per il trattamento della retinite pigmentosa |
| EP4233867A1 (de) | 2022-02-24 | 2023-08-30 | Nicox SA | Pde5 hemmer zur verwendung bei der behandlung der anterioren ischämischen optischen neuropathie |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0688973B2 (ja) | 1987-03-12 | 1994-11-09 | 京都薬品工業株式会社 | １，４−ジヒドロピリジン誘導体 |
| JPH03145464A (ja) * | 1989-10-30 | 1991-06-20 | Kyoto Yakuhin Kogyo Kk | 光学活性１，４―ジヒドロピリジン誘導体 |
| JP3145464B2 (ja) | 1991-09-30 | 2001-03-12 | 株式会社リコー | デカール装置 |
| EP0639986A1 (de) | 1992-05-13 | 1995-03-01 | Alcon Laboratories, Inc. | Topischeopthalmische zusammensetzungen, die eine kombination von calcium-antagonisten mit bekannten antiglaukommitteln enthalten |
| DK0577913T3 (da) | 1992-07-08 | 1998-01-26 | Santen Oy | Ophthalmisk præparat indeholdende timolol-hemihydrat |
| US5922773A (en) * | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
| US5435998A (en) * | 1994-08-03 | 1995-07-25 | Abelson; Mark B. | Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents |
-
1997
- 1997-10-23 CA CA002270119A patent/CA2270119A1/en not_active Abandoned
- 1997-10-23 DE DE69739190T patent/DE69739190D1/de not_active Expired - Lifetime
- 1997-10-23 WO PCT/JP1997/003866 patent/WO1998018471A1/ja active Application Filing
- 1997-10-23 ES ES97909623T patent/ES2317650T3/es not_active Expired - Lifetime
- 1997-10-23 US US09/297,197 patent/US6451799B1/en not_active Expired - Fee Related
- 1997-10-23 JP JP52027698A patent/JP4828670B2/ja not_active Expired - Fee Related
- 1997-10-23 EP EP97909623A patent/EP0968716B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2317650T3 (es) | 2009-04-16 |
| WO1998018471A1 (fr) | 1998-05-07 |
| JP4828670B2 (ja) | 2011-11-30 |
| EP0968716B1 (de) | 2008-12-31 |
| EP0968716A4 (de) | 2003-05-21 |
| US6451799B1 (en) | 2002-09-17 |
| CA2270119A1 (en) | 1998-05-07 |
| EP0968716A1 (de) | 2000-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69630479D1 (de) | Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten | |
| DE69830728D1 (de) | Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz | |
| DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
| DE69509544D1 (de) | Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten | |
| ATE271038T1 (de) | 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen | |
| ATE195527T1 (de) | Neue steroidester zur behandlung von hauterkrankungen | |
| DE69626539D1 (de) | topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen | |
| ATE472325T1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
| NO995221D0 (no) | Sulfonamider for behandling av endotelinmedierte sykdommer | |
| DE69806801T2 (de) | Galenische präparation zur prävention und behandlung von hepatokarzinomen | |
| ATE201992T1 (de) | Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen | |
| DE50010284D1 (de) | Arzneimittel zur behandlung von bluthochdruck | |
| DE69824576D1 (de) | Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen | |
| DE60027209D1 (de) | Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen | |
| DE69620691T2 (de) | Therapeutisches Mittel zur Behandlung der Hypercholesterinämie | |
| DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
| DE69807466D1 (de) | Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten | |
| DE69420229T2 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
| DE69825319D1 (de) | Präparat zur vorbeugung und behandlung von entzündungen | |
| DE69829217D1 (de) | Vorrichtung zur therapeutischen behandlung von blutgefässen | |
| DE69822297D1 (de) | Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten | |
| DE69739190D1 (de) | Arzneimittel zur behandlung von oculären kreislauferkrankungen | |
| DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
| DE69735417D1 (de) | 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen | |
| HUP0000785A3 (en) | Ointment for the treatment of burns and other skin diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |